A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer

NCT07654400 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive-stage Small-cell Lung Cancer

Interventions

DRUG: BL-M14D1
DRUG: Atezolizumab

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]